Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Improvements of Drug-resistant Species To Emerge as Key Opportunity for Companies Dealing with E-coli Testing Market

Transparency Market Research
Posted on: 13 Oct 16
Improvements of Drug-resistant Species To Emerge as Key Opportunity for Companies Dealing with E-coli Testing Market

Escherichia coli (E.coli) is a Gram negative rod-shaped bacteria commonly found in intestines of warm blooded animals. Majority of the E.coli strains are harmless, however certain strains are known to cause serious medical complications. These include gastrointestinal infections, cholecystitis, bacteremia, cholangitis, urinary tract infection (UTI), neonatal meningitis and pneumonia and mainly spreads through contaminated food or water. As this organism is found in intestinal tract of humans, it is considered as an indicator of fecal contamination.Hence food and water samples are regularly tested for E.coli to avoid foodborne infections.Environmental Protection Agency (EPA) regulates drinking and environmental water, while bottled water standards are regulated by the Food and Drug Administration (FDA), in the U.S. Membrane filtration, multiple tube fermentation and presence/absence (P/A) tests are approved for testing water samples for municipal water suppliers, waste water treatment plants, bottled water organizations and private well.

Escherichia coli (E. coli) are a diverse and large group of bacteria found in the environment, several foods, and intestines of animals and peoplehumans. Although the majority of strains of E. coli aren’t harmful, others can cause intestinal infections. The key symptoms of an E. coli infection include abdominal pain, diarrhea, and kidney failure. People having weakened immune systems, older adults, young children, and pregnant women are at a high risk of developing such complications. The kinds of E. coli that cause diarrhea are transmitted via contaminated food or water or via contact with affected persons or animals.

Get PDF Brochure for more Professional and Technical industry insights: http://bit.ly/2e7GnqJ

As per the report, the increasing initiatives taken by governments in favor of E. coli tests and the rising spread and high morbidity of E. coli are amongst the prime factors driving the growth of the market for E. coli testing. In addition, the development of drug-resistant species is also having a positive impact on the growth of the market. Polymerase chain reaction (PCR) tests being used for environment water testing has emerged as a key growth opportunity in the market. On the other hand, the soaring prices of enzyme-substrate tests in comparison with separate apparatus tests are inhibiting the growth of the market.

In terms of testing method, the report segments the market into clinical testing and environmental testing. The segment of environmental testing is further segmented into membrane filtration (MF), enzyme-substrate methods, and multiple tube fermentation (MTF). On the other hand, the segment of clinical testing is further segmented into enzyme immunoassays (EIA), polymerase chain reaction (PCR) tests, and others. Amongst these, on the basis of revenue, the segment of enzyme substrate tests hold the largest share of 80% in the market. On the basis of volume, this segment constitutes a share of 40% in the market. In terms of revenue, the segment of membrane filtration holds the largest share in the market.

On the basis of end use, the report segments the market into clinical and environmental. The segment of clinical E. coli testing is further segmented into diagnostic laboratories, hospitals, and physician offices. The segment of environmental E-coli testing is further segmented into bottle water suppliers, home and drinking water suppliers, waste water treatment organizations, and others including private well owners, government agencies, farm water testing, and groundwater testing, among others. Amongst these, E. coli testing has been highly demanded by bottle water suppliers and home and drinking water suppliers.

Geographically, the market is segmented into Europe, North America, Latin America, Africa, Rest of Africa, Asia Pacific, and Rest of the World (RoW). Amongst these, Europe led the market in 2013 due to the outbreak of foodborne infections within Germany in 2011 due to the E. coli O104:H4 strain. On the other hand, Asia Pacific is anticipated to be the most lucrative region in the market and is predicted to rise at a 6.92% CAGR from 2014 to 2022. This is owing to the increasing water pollution in rising economies such as India, Japan, and China.

View exclusive Global strategic Business report :  http://www.transparencymarketresearch.com/e-coli-testing-market.html

A new Transparency Market Research report states that the global E. coli testing market stood at US$1.2 bn in 2013 .and is predicted to reach US$2.1 bn by 2022. It is expected to expand at a CAGR of 6.58% from 2014 to 2022. The title of the report is, “E.coli Testing (Environmental Testing and Clinical Testing) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.”

Key companies operating in the global E.coli testing market are focusing on introducing E.coli testing methods to maintain their dominance. Some of the key players operating in the global market are IDEXX Laboratories, HyServe GmbH & Co. KG, Abbott Laboratories, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Charm Sciences, and CPI International. 

 

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

 

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website:  http://www.transparencymarketresearch.com/

For more information:
www.transparencymarketresearch.com

Editor's Details

Ranu Kurmi
Transparency Market Research
www.transparencymarketresearch.com
+1-518-618-1030
ranu.k@transparencymarketresearch.com

Last updated on: 13/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.